Structure, properties, mechanisms, and assays of cysteine protease inhibitors: cystatins and E-64 derivatives.

PubWeight™: 0.98‹?› | Rank: Top 15%

🔗 View Article (PMID 7651220)

Published in Methods Enzymol on January 01, 1995

Authors

N Katunuma1, E Kominami

Author Affiliations

1: Institute for Health Sciences, Tokushima Bunri University, Japan.

Articles by these authors

(truncated to the top 100)

LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J (2000) 41.48

A ubiquitin-like system mediates protein lipidation. Nature (2000) 10.61

ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ (2006) 5.18

Apg7p/Cvt2p: A novel protein-activating enzyme essential for autophagy. Mol Biol Cell (1999) 4.68

The human homolog of Saccharomyces cerevisiae Apg7p is a Protein-activating enzyme for multiple substrates including human Apg12p, GATE-16, GABARAP, and MAP-LC3. J Biol Chem (2000) 3.33

Sequestration of cytoplasmic enzymes in an autophagic vacuole-lysosomal system induced by injection of leupeptin. J Biol Chem (1983) 3.08

Membrane markers of endoplasmic reticulum preserved in autophagic vacuolar membranes isolated from leupeptin-administered rat liver. J Biol Chem (1991) 2.51

Autolysosomal membrane-associated betaine homocysteine methyltransferase. Limited degradation fragment of a sequestered cytosolic enzyme monitoring autophagy. J Biol Chem (1999) 2.23

Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci (2000) 2.21

Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci (1995) 1.95

Interaction of the Unc-51-like kinase and microtubule-associated protein light chain 3 related proteins in the brain: possible role of vesicular transport in axonal elongation. Brain Res Mol Brain Res (2000) 1.80

Molecular cloning of human ornithine aminotransferase mRNA. Proc Natl Acad Sci U S A (1986) 1.75

Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice. J Clin Invest (1996) 1.67

The C-terminal region of an Apg7p/Cvt2p is required for homodimerization and is essential for its E1 activity and E1-E2 complex formation. J Biol Chem (2001) 1.60

Regulation of cell surface expression of CTLA-4 by secretion of CTLA-4-containing lysosomes upon activation of CD4+ T cells. J Immunol (2000) 1.39

Molecular characterization of mammalian homologues of class C Vps proteins that interact with syntaxin-7. J Biol Chem (2001) 1.37

Regulation of a novel pathway for cell death by lysosomal aspartic and cysteine proteinases. Neuroscience (1999) 1.34

Molecular cloning and sequencing of cDNA for rat cathepsin H. Homology in pro-peptide regions of cysteine proteinases. FEBS Lett (1987) 1.34

Constitutive autophagy: vital role in clearance of unfavorable proteins in neurons. Cell Death Differ (2007) 1.34

Studies on new intracellular proteases in various organs of rat. 1. Purification and comparison of their properties. Eur J Biochem (1975) 1.34

Cysteine proteinases in GH4C1 cells, a rat pituitary tumor cell line, are secreted by the constitutive and regulated secretory pathways. Eur J Cell Biol (1995) 1.28

Characterization of new fluorogenic substrates for the rapid and sensitive assay of cathepsin E and cathepsin D. J Biochem (1999) 1.28

Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins. J Enzyme Inhib (1990) 1.26

Expression of proteinases and inflammatory cytokines in subchondral bone regions in the destructive joint of rheumatoid arthritis. Rheumatology (Oxford) (2001) 1.24

Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci U S A (1991) 1.23

Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse. Biochem Biophys Res Commun (1995) 1.21

Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo. J Biochem (1980) 1.19

Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur J Neurosci (1998) 1.19

Autophagy in embryonic erythroid cells: its role in maturation. Eur J Cell Biol (2000) 1.18

A new enzyme that specifically inactivates apo-protein of pyridoxal enzymes. Biochem Biophys Res Commun (1971) 1.17

Distribution of cathepsins B and H in rat tissues and peripheral blood cells. J Biochem (1985) 1.15

Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes. Clin Sci (Lond) (1995) 1.14

An ultrastructural and immunohistochemical study of PC12 cells during apoptosis induced by serum deprivation with special reference to autophagy and lysosomal cathepsins. Arch Histol Cytol (1998) 1.12

Phalloidin-induced accumulation of myosin in rat hepatocytes is caused by suppression of autolysosome formation. Eur J Biochem (1990) 1.12

Selective localization of Bcl-2 to the inner mitochondrial and smooth endoplasmic reticulum membranes in mammalian cells. Cell Death Differ (2000) 1.11

Molecular basis of intracellular regulation of thiol proteinase inhibitors. Curr Top Cell Regul (1985) 1.11

Structures and functions of lysosomal thiol proteinases and their endogenous inhibitor. Curr Top Cell Regul (1983) 1.11

Effect of proteinase inhibitors on intracellular processing of cathepsin B, H and L in rat macrophages. FEBS Lett (1988) 1.11

Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J Neurosci (2001) 1.10

Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo. FEBS Lett (1999) 1.09

Procathepsin L degrades extracellular matrix proteins in the presence of glycosaminoglycans in vitro. Biochem Biophys Res Commun (1995) 1.05

Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Immunol Lett (1994) 1.04

Purification and properties of proteinase B from yeast. Biochim Biophys Acta (1981) 1.03

Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line. Am J Physiol (1998) 1.02

Molecular weight-dependent effects of hyaluronate on the arthritic synovium. Arch Histol Cytol (1998) 1.01

Deimination of 70-kD nuclear protein during epidermal apoptotic events in vitro. J Histochem Cytochem (1998) 1.01

Cloning and characterization of two neural-salient serine/arginine-rich (NSSR) proteins involved in the regulation of alternative splicing in neurones. Genes Cells (1999) 1.00

Properties of a specific protease for pyridoxal enzymes and its biological role. J Biol Chem (1972) 0.99

Lysosomal cysteine and aspartic proteinases, acid phosphatase, and an endogenous cysteine proteinase inhibitor, cystatin-beta, in rat osteoclasts. J Histochem Cytochem (1993) 0.99

Purification and tissue distribution of rat cathepsin L. J Biochem (1986) 0.99

Molecular cloning and sequencing of cDNA for rat cathepsin L. FEBS Lett (1987) 0.98

Different immunolocalizations of cathepsins B, H, and L in the liver. J Histochem Cytochem (1985) 0.97

Crystallization and properties of human liver ornithine aminotransferase. J Biochem (1982) 0.96

Three forms of thiol proteinase inhibitor from rat liver formed depending on the oxidation-reduction state of a sulfhydryl group. J Biol Chem (1984) 0.96

Cytoplasmic processing of human profilaggrin by active mu-calpain. Biochem Biophys Res Commun (1997) 0.96

Gene regulation and extracellular functions of procathepsin L. Biol Chem (1998) 0.96

Endogenous thiol protease inhibitor from rat liver. Biochem Biophys Res Commun (1981) 0.94

Cathepsin L activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. Am Rev Respir Dis (1993) 0.94

Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Exp Neurol (1999) 0.92

A new function of kininogens as thiol-proteinase inhibitors: inhibition of papain and cathepsins B, H and L by bovine, rat and human plasma kininogens. FEBS Lett (1985) 0.92

Dynamic changes of cathepsins B and L expression in the monkey hippocampus after transient ischemia. Biochem Biophys Res Commun (1996) 0.92

Participation of cathepsins B and D in apoptosis of PC12 cells following serum deprivation. Biochem Biophys Res Commun (1998) 0.91

Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase. J Biochem (2000) 0.90

Different tissue distributions of two types of thiol proteinase inhibitors from rat liver and epidermis. J Biochem (1984) 0.90

Multiple processing of procathepsin L to cathepsin L in vivo. Biochem Biophys Res Commun (1998) 0.90

A new enzyme that specifically inactivates apo-protein of NAD-dependent dehydrogenases. Biochem Biophys Res Commun (1971) 0.90

Egr family member proteins are involved in the activation of the cathepsin L gene in v-src-transformed cells. Biochem Biophys Res Commun (1997) 0.90

Leupeptin-induced appearance of partial fragment of betaine homocysteine methyltransferase during autophagic maturation in rat hepatocytes. J Biochem (2001) 0.90

Processing of cathepsins L, B and D in psoriatic epidermis. Arch Dermatol Res (1997) 0.89

Interaction of Doc2 with tctex-1, a light chain of cytoplasmic dynein. Implication in dynein-dependent vesicle transport. J Biol Chem (1998) 0.89

Cysteine proteinases in bronchoalveolar epithelial cells and lavage fluid of rat lung. J Histochem Cytochem (1991) 0.89

Activation of the intramyofibral autophagic-lysosomal system in muscular dystrophy. Am J Pathol (1987) 0.88

Autodegradation of lysosomal cysteine proteinases. Biochem Biophys Res Commun (1987) 0.88

Immunocytochemical localization of lysosomal cysteine and aspartic proteinases, and ubiquitin in rat epidermis. Arch Histol Cytol (1997) 0.87

Processing and transport of the precursor of cathepsin C during its transfer into lysosomes. Arch Biochem Biophys (1993) 0.87

Specific delay of degradation of mitochondrial ATP synthase subunit c in late infantile neuronal ceroid lipofuscinosis (Batten disease). J Neurochem (1995) 0.87

Abnormal increases of lysosomal cysteinine proteinases in rimmed vacuoles in the skeletal muscle. Am J Pathol (1986) 0.87

Purification and characterization of thiol proteinase inhibitor from rat liver. J Biol Chem (1982) 0.87

Visual impairment and REP-1 gene mutations in Japanese choroideremia patients. Ophthalmic Genet (1999) 0.86

Amino acid sequence of rat epidermal thiol proteinase inhibitor. Biochem Biophys Res Commun (1984) 0.86

Amino acid sequence of rat liver thiol proteinase inhibitor. Biochem Biophys Res Commun (1983) 0.86

Abnormal expression of lysosomal cysteine proteinases in muscle wasting diseases. Rev Physiol Biochem Pharmacol (1987) 0.86

Regulation of intracellular enzyme levels by group specific proteases in various organs. Adv Enzyme Regul (1973) 0.86

A lysosomal proteinase, the late infantile neuronal ceroid lipofuscinosis gene (CLN2) product, is essential for degradation of a hydrophobic protein, the subunit c of ATP synthase. J Neurochem (1999) 0.86

A new sensitive and convenient assay of ornithine aminotransferase. J Nutr Sci Vitaminol (Tokyo) (1983) 0.85

Studies of new intracellular proteases in various organs of rats. Participation of proteases in degradation of ornithine aminotransferase in vitro and in vivo. Eur J Biochem (1976) 0.85

Comparison of properties of thiol proteinase inhibitors from rat serum and liver. J Biol Chem (1982) 0.85

Increases in cathepsins B and L and thiol proteinase inhibitor in muscle of dystrophic hamsters. Their localization in invading phagocytes. J Biochem (1984) 0.85

Proenzyme from of cathepsin L produced by thymic epithelial cells promotes proliferation of immature thymocytes in the presence of IL-1, IL-7, and anti-CD3 antibody. Cell Immunol (1993) 0.85

Immunological studies on cathepsins B and H from rat liver. J Biochem (1982) 0.85

Genomic structure and PCR-SSCP analysis of the human CD40 ligand gene: its application to prenatal screening for X-linked hyper-IgM syndrome. Hum Genet (1996) 0.84

An immunocytochemical study on co-localization of cathepsin B and atrial natriuretic peptides in secretory granules of atrial myoendocrine cells of rat heart. J Histochem Cytochem (1989) 0.84

Participation of cathepsins B, H, and L in perikaryal condensation of CA1 pyramidal neurons undergoing apoptosis after brief ischemia. Adv Exp Med Biol (1996) 0.84

Multi-step processing of procathepsin L in vitro. FEBS Lett (1994) 0.84

Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged. Virchows Arch A Pathol Anat Histopathol (1993) 0.84

Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis. Biochem Biophys Res Commun (2000) 0.84

Properties of fructose-1,6-bisphosphate aldolase inactivating enzymes in rat liver lysosomes. Biochim Biophys Acta (1981) 0.84

Calpain and cathepsins in the skeletal muscle of inflammatory myopathies. Eur Neurol (1997) 0.84

Abnormal degradative pathway of mitochondrial ATP synthase subunit c in late infantile neuronal ceroid-lipofuscinosis (Batten disease). Am J Med Genet (1995) 0.83

Inhibitions of degradation of rat liver aldolase and lactic dehydrogenase by N-[N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl] agmatine or leupeptin in vivo. Biochem Biophys Res Commun (1980) 0.83